HCA Healthcare (HCA) Stock Forecast & Price Target

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

HCA Analyst Ratings

Moderate Buy

13 Buy

7 Hold

1 Sell

Based on 21 analysts giving stock ratings to

HCA

Healthcare

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

HCA Stock 12 Month Forecast

Average Price Target

$8,378.73

▲(14.85% Upside)

Based on 21 Wall Street analysts offering 12 month price targets for HCA Healthcare in the last 3 months. The average price target is $8,378.73 with a high forecast of $10,658.47 and a low forecast of $6,995.20. The average price target represents a 14.85% change from the last price of $7,295.63.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6423":"$6,423","7482":"$7,482","8541":"$8,541","9600":"$9,600","10659":"$10,659"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":10658.46878784,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$11K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8378.73266768842,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$8K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6995.1954048,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$7K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6423,7482,8541,9600,10659],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7461.18,7707.125291372308,7953.070582744615,8199.015874116923,8444.96116548923,8690.90645686154,8936.851748233847,9182.797039606154,9428.74233097846,9674.68762235077,9920.632913723077,10166.578205095386,10412.523496467693,{"y":10658.46878784,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7461.18,7531.760974437571,7602.3419488751415,7672.922923312713,7743.503897750284,7814.084872187854,7884.665846625425,7955.246821062996,8025.827795500567,8096.408769938137,8166.989744375708,8237.570718813278,8308.15169325085,{"y":8378.73266768842,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7461.18,7425.335031138462,7389.490062276924,7353.6450934153845,7317.800124553846,7281.955155692308,7246.11018683077,7210.26521796923,7174.420249107692,7138.575280246154,7102.730311384616,7066.885342523076,7031.040373661538,{"y":6995.1954048,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7739.354,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8538.269,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9390.058,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8468.467,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8115.624,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8988.406,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8930.457,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8127.96,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6424.674,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6842.235,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7061.764,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7134.627,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7461.18,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$10,658

Average Price Target$8,379

Lowest Price Target$6,995

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Ryan Langston

TD Cowen

$7,934.02→$8,467.87

Buy

16.07%

Upside

Reiterated

10/12/26

Analysts Are Bullish on These Healthcare Stocks: Alignment Healthcare (ALHC), HCA Healthcare (HCA)

Ben Hendrix

RBC Capital

$8,007.66→$9,130.57

Buy

25.15%

Upside

Reiterated

10/07/26

HCA Healthcare price target raised to $496 from $435 at RBC CapitalHCA Healthcare price target raised to $496 from $435 at RBC Capital

Andrew Mok CFA

Barclays

$7,124.05

Hold

-2.35%

Downside

Reiterated

10/07/26

Barclays Remains a Hold on HCA Healthcare (HCA)

Lance Wilkes

Bernstein

$7,841.98

Hold

7.49%

Upside

Reiterated

10/05/26

Bernstein Sticks to Their Hold Rating for HCA Healthcare (HCA)

Andrew Cooper

Raymond James

―

Hold

―

Reiterated

09/28/26

Analysts Offer Insights on NA Companies: HCA Healthcare (NYSE: HCA), Grupo Televisa, S.A.B. (NYSE: TV) and Pasqal Holding SA (NASDAQ: PSQL)

Sean Dodge

BMO Capital

$9,112.16

Buy

24.90%

Upside

Initiated

09/22/26

HCA Healthcare initiated with an Outperform at BMO CapitalHCA Healthcare initiated with an Outperform at BMO Capital

Brian Tanquilut

Jefferies

$8,283.78

Buy

13.54%

Upside

Reiterated

09/17/26

Jefferies Sticks to Its Buy Rating for HCA Healthcare (HCA)

Whit Mayo

Leerink Partners

―

Buy

―

Reiterated

09/17/26

Analysts Offer Insights on NA Companies: Douglas AG (Other OTC: DOUDF) and HCA Healthcare (NYSE: HCA)

Benjamin Rossi

J.P. Morgan

$7,823.57

Hold

7.24%

Upside

Reiterated

08/24/26

J.P. Morgan Reaffirms Their Hold Rating on HCA Healthcare (HCA)

Kevin Fischbeck

Bank of America Securities

$7,363.36→$7,823.57

Hold

7.24%

Upside

Reiterated

08/10/26

HCA Healthcare (HCA) Receives a Hold from Bank of America Securities

David Toung

Argus Research

$9,204.2

Buy

26.16%

Upside

Assigned

08/07/26

Argus Research Sticks to Its Buy Rating for HCA Healthcare (HCA)

David S Macdonald

Truist Financial

$9,112.16

Buy

24.90%

Upside

Reiterated

08/05/26

Truist Financial Sticks to Its Buy Rating for HCA Healthcare (HCA)

Stephen Baxter

Wells Fargo

$6,792.7→$7,013.6

Hold

-3.87%

Downside

Assigned

08/03/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: AptarGroup (NYSE: ATR), Myriad Genetics (NASDAQ: MYGN) and HCA Healthcare (NYSE: HCA)

Ann Hynes

Mizuho Securities

$9,664.41→$8,743.99

Buy

19.85%

Upside

Reiterated

07/28/26

HCA Healthcare price target lowered to $475 from $525 at MizuhoHCA Healthcare price target lowered to $475 from $525 at Mizuho

A.J. Rice

UBS

$11,689.34→$10,658.47

Buy

46.09%

Upside

Reiterated

07/27/26

HCA Healthcare price target lowered to $579 from $635 at UBSHCA Healthcare price target lowered to $579 from $635 at UBS

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Ryan Langston

TD Cowen

$7,934.02→$8,467.87

Buy

16.07%

Upside

Reiterated

10/12/26

Analysts Are Bullish on These Healthcare Stocks: Alignment Healthcare (ALHC), HCA Healthcare (HCA)

Ben Hendrix

RBC Capital

$8,007.66→$9,130.57

Buy

25.15%

Upside

Reiterated

10/07/26

HCA Healthcare price target raised to $496 from $435 at RBC CapitalHCA Healthcare price target raised to $496 from $435 at RBC Capital

Andrew Mok CFA

Barclays

$7,124.05

Hold

-2.35%

Downside

Reiterated

10/07/26

Barclays Remains a Hold on HCA Healthcare (HCA)

Lance Wilkes

Bernstein

$7,841.98

Hold

7.49%

Upside

Reiterated

10/05/26

Bernstein Sticks to Their Hold Rating for HCA Healthcare (HCA)

Andrew Cooper

Raymond James

―

Hold

―

Reiterated

09/28/26

Analysts Offer Insights on NA Companies: HCA Healthcare (NYSE: HCA), Grupo Televisa, S.A.B. (NYSE: TV) and Pasqal Holding SA (NASDAQ: PSQL)

Sean Dodge

BMO Capital

$9,112.16

Buy

24.90%

Upside

Initiated

09/22/26

HCA Healthcare initiated with an Outperform at BMO CapitalHCA Healthcare initiated with an Outperform at BMO Capital

Brian Tanquilut

Jefferies

$8,283.78

Buy

13.54%

Upside

Reiterated

09/17/26

Jefferies Sticks to Its Buy Rating for HCA Healthcare (HCA)

Whit Mayo

Leerink Partners

―

Buy

―

Reiterated

09/17/26

Analysts Offer Insights on NA Companies: Douglas AG (Other OTC: DOUDF) and HCA Healthcare (NYSE: HCA)

Benjamin Rossi

J.P. Morgan

$7,823.57

Hold

7.24%

Upside

Reiterated

08/24/26

J.P. Morgan Reaffirms Their Hold Rating on HCA Healthcare (HCA)

Kevin Fischbeck

Bank of America Securities

$7,363.36→$7,823.57

Hold

7.24%

Upside

Reiterated

08/10/26

HCA Healthcare (HCA) Receives a Hold from Bank of America Securities

David Toung

Argus Research

$9,204.2

Buy

26.16%

Upside

Assigned

08/07/26

Argus Research Sticks to Its Buy Rating for HCA Healthcare (HCA)

David S Macdonald

Truist Financial

$9,112.16

Buy

24.90%

Upside

Reiterated

08/05/26

Truist Financial Sticks to Its Buy Rating for HCA Healthcare (HCA)

Stephen Baxter

Wells Fargo

$6,792.7→$7,013.6

Hold

-3.87%

Downside

Assigned

08/03/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: AptarGroup (NYSE: ATR), Myriad Genetics (NASDAQ: MYGN) and HCA Healthcare (NYSE: HCA)

Ann Hynes

Mizuho Securities

$9,664.41→$8,743.99

Buy

19.85%

Upside

Reiterated

07/28/26

HCA Healthcare price target lowered to $475 from $525 at MizuhoHCA Healthcare price target lowered to $475 from $525 at Mizuho

A.J. Rice

UBS

$11,689.34→$10,658.47

Buy

46.09%

Upside

Reiterated

07/27/26

HCA Healthcare price target lowered to $579 from $635 at UBSHCA Healthcare price target lowered to $579 from $635 at UBS

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

IMUXImmunic

OMCLOmnicell

LGNDLigand Pharma

KURAKura Oncology

HITIHigh Tide

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering HCA Healthcare

3 Months

Sarah JamesCantor Fitzgerald

Success Rate

15/19 ratings generated profit

Average Return

+8.16%

Copying Sarah James's trades and holding each position for 3 Months would result in 78.95% of your transactions generating a profit, with an average return of +8.16% per trade.

1 Year

Sarah JamesCantor Fitzgerald

Success Rate

18/19 ratings generated profit

Average Return

+20.32%

Copying Sarah James's trades and holding each position for 1 Year would result in 94.74% of your transactions generating a profit, with an average return of +20.32% per trade.

2 Years

Whit MayoLeerink Partners

Success Rate

47/47 ratings generated profit

Average Return

+52.50%

Copying Whit Mayo's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +52.50% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HCA Analyst Recommendation Trends

Rating

Jun 26

Jul 26

Aug 26

Sep 26

Oct 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, HCA has received 9 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. HCA average Analyst price target in the past 3 months is 8,378.73.

Each month's total comprises the sum of three months' worth of ratings.

HCA Financial Forecast

HCA Earnings Forecast

Next quarter’s earnings estimate for HCA is $122.60 with a range of $107.38 to $135.38. The previous quarter’s EPS was $139.80. HCA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year HCA has Performed in-line its overall industry.

HCA Sales Forecast

Next quarter’s sales forecast for HCA is $356.08B with a range of $346.29B to $365.97B. The previous quarter’s sales results were $372.61B. HCA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year HCA has Performed in-line its overall industry.

HCA Stock Forecast FAQ

What is MX:HCA’s average 12-month price target, according to analysts?

Based on analyst ratings, HCA Healthcare’s 12-month average price target is 8,378.73.

What is MX:HCA’s upside potential, based on the analysts’ average price target?

HCA Healthcare has 14.85% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is HCA Healthcare a Buy, Sell or Hold?

HCA Healthcare has a consensus rating of Moderate Buy, which is based on 13 buy ratings, 7 hold ratings and 1 sell ratings.

What is HCA Healthcare’s share price target?

The average share price target for HCA Healthcare is 8,378.73. This is based on 21 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $10,658.47 ,and the lowest forecast is $6,995.20. The average share price target represents 14.85% Increase from the current price of $7,295.63.

What do analysts say about HCA Healthcare?

HCA Healthcare’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 21 Wall Streets Analysts.

How can I buy shares of HCA Healthcare?

To buy shares of MX:HCA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Analyst Ratings

HCA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering HCA Healthcare

HCA Analyst Recommendation Trends

HCA Financial Forecast

HCA Earnings Forecast

HCA Sales Forecast

HCA Stock Forecast FAQ

Detailed List of Analyst Forecasts